Jacopo Olivieri

10PUBLICATIONS
111CO-AUTHORS
Basic pharmacologyGene and molecular therapyHaematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 07, 2026
Bendamustine in indolent lymphoma: Letting the dust settle down.

|Mar 14, 2026
A Modified-Delphi Consensus on the Management of Patients with FLT3-Mutated AML.

Jacopo Olivieri, Emanuele Angelucci, Roberto Cairoli

|Dec 30, 2025
Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL).

Maria Elena Carazzolo, Francesca Maria Quaglia, Antonino Aparo

|Aug 05, 2025
Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis.

Anna Dodero, Giusy Ceparano, Beatrice Casadei

|Jun 12, 2025
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study.

Alberto Fresa, Idanna Innocenti, Annamaria Tomasso

|Mar 19, 2025
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi.

Rexhep Durmo, Stephane Chauvie, Federico Fallanca

Pageof 2

Frequent Collaborators

4 joint publications

Pier Luigi Zinzani

3 joint publications

Vittorio Ruggero Zilioli

3 joint publications

Paolo Corradini

3 joint publications

Stephane Chauvie